In-vitro synergistic activity between ethambutol and fluorinated qoinolones against Mycobacterium avium complex
- 1 September 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 24 (3), 317-324
- https://doi.org/10.1093/jac/24.3.317
Abstract
Ciprofloxacin, ofloxacin and norfloxacin were ineffective at clinically relevant concentrations against the Mycobaetertum avium complex (MAC) in vitro as measured by radiometric respirometry. Only two of 30 clinical isolates of MAC were susceptible to any of the tested quinolone. By contrast good antibacterial activity was obtained when any of the quinolones was combined with ethambutol. The synergistic effect was most pronounced for the combination of ethambutol and ciprofloxacin, to which 76 of 100 strains were susceptible. It is suggested that the synergism is based on an enhanced penetration of the quinolones by ethambutol.Keywords
This publication has 17 references indexed in Scilit:
- Comparative in-vitro activity of five fluoroquinolones against mycobacteriaJournal of Antimicrobial Chemotherapy, 1987
- In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987
- INVITRO ACTIVITY OF CIPROFLOXACIN AND OFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-AFRICANUM, MYCOBACTERIUM-KANSASII, AND STRAINS OF BCG1986
- Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1986
- In-vitro susceptibility of mycobacteria to ciprofloxacinJournal of Antimicrobial Chemotherapy, 1985
- Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristicsJournal of Clinical Microbiology, 1985
- THERAPEUTIC EFFECT OF A NEW ANTIBACTERIAL SUBSTANCE OFLOXACIN (DL8280) ON PULMONARY TUBERCULOSISPublished by Elsevier ,1985
- The pharmacokinetics and tissue penetration of ofloxacinJournal of Antimicrobial Chemotherapy, 1984
- Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?Antimicrobial Agents and Chemotherapy, 1981
- MYCOBACTERIA - LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE1963